Telos Capital Partners help entrepreneurial businesses transform and scale their organizations.

Telos Capital Partners

Our Mission

Our mission is to help small businesses deliver superior products and services by assisting with comprehensive development, operational and marketing strategies that propel future growth. We accomplish this by partnering with management teams to improve operations, support organic growth initiatives, and complete add-on acquisitions. We create value for all stakeholders by building companies that are not just bigger, but are qualitatively better and more well-positioned strategically.


Work hard, always do the right thing, and consistently follow through by doing what we say we are going to do.
Meet challenges head on. Acknowledge problems so that they may be dealt with in a timely manner.
Ensure that both we and our companies are fully compliant in legal, tax, regulatory and environmental matters.
Encourage teamwork and the exchange of differing viewpoints while building consensus.
Strive for continuous improvement in every aspect of our business and our companies’ businesses.
Take the high road in everything that we do and always stay positive and never give up. Ever.
As entrepreneurs with a history of success, we know what it takes to make your small business thrive.


24 Nov: BDA Advises Flex and Escientia Life Sciences on Sale of Escientia to Deccan Fine Chemicals

New York, NY, November 24, 2020 –(– BDA Partners is pleased to announce that its clients, Flex Ltd. and Escientia Life Sciences, have sold a controlling stake in Escientia to Deccan Fine Chemicals, a specialty chemicals manufacturer, based in Hyderabad, India. Terms of the transaction were not disclosed. Escientia has operations in both the US and India. Escientia is a fast-growing pharmaceutical CDMO (contract development & manufacturing organization) for leading life sciences companies. Escientia focuses on developing and making complex APIs (active pharma ingredients) for human and animal health applications. Founded in 2007 by senior executives from large, innovative American pharma companies, with experience across drug discovery, development, and commercialization, Escientia has been a key partner in 120 drug development/manufacturing projects, many of which have become commercialized therapeutics. The selling shareholder is Flex, a provider of technology, manufacturing, and supply chain solutions, which partnered with Escientia on the design and…

19 Nov: Strategic Brand Expansion: XTIVIA Acquires Innovative ITSM/ITIL Firm RightStar

XTIVIA, Inc. is taking big steps to grow its diverse collection of IT managed service offerings. Today, they announced that they will be expanding their brand of services with the acquisition of RightStar, an ITSM/ITIL and DevOps consulting company. The acquisition marks another milestone in XTIVIA’s strategic investments and highlights their pursuit of comprehensive IT services in all verticals. Colorado Springs, CO, November 19, 2020 –(– XTIVIA, Inc., an innovative IT solutions provider, is announcing today that they will be expanding their brand family with the acquisition of RightStar, an ITSM/ITIL and DevOps consulting company. This opportunity builds on the encompassing IT service suite that has won XTIVIA prominent recognition over the last 28 years. “The addition of RightStar expands on XTIVIA’s already diverse offerings in IT managed services. Welcoming them to our team allows us to continue working toward our mission of delivering exceptional software solutions that enable our…